“…In addition, not only factors related to the compromised immune system such as DM, malignancies, or renal or hepatic dysfunction but also those related to abscess or others such as abscess size, laboratory data, fever, or shock were investigated for significant correlation with initial treatment failure and recurrence within 1 month after cure of abscesses and related infection [10] . Shock was defined as a systolic blood pressure of ≤ 90 mm Hg during hospitalization [11] .…”
Section: Examined Factors and Clinical Risk Factorsmentioning
Introduction: This study examined the risk factors for initial treatment failure in renal or retroperitoneal abscess as a multicenter study. Materials and Methods: This retrospective analysis investigated consecutive patients with renal or retroperitoneal abscess who were hospitalized in Japan. The outcomes of these patients were classified into “cured” and “failure or recurrence.” The potential clinical risk factors examined were abscess size, diabetes mellitus, major organ failure, laboratory data, fever, drainage, and causative organisms, for instance. Results: Of the 74 patients, 40 (54.1%) were diagnosed with renal abscess and 34 (45.9%) with retroperitoneal abscess, 51 (68.9%) were cured by initial treatments, and 23 (31.1%) underwent failure or relapse; 33 (44.6%) were men and 41 (55.4%) were women. In detail, 36 patients were cured by conservative therapy only. Our multivariate analysis data showed that renal failure was the only significant factor for initial treatment failure (p = 0.0281). Conclusions: Our multivariate analysis showed that renal failure was a significant risk factor for initial treatment failure or recurrence.
“…In addition, not only factors related to the compromised immune system such as DM, malignancies, or renal or hepatic dysfunction but also those related to abscess or others such as abscess size, laboratory data, fever, or shock were investigated for significant correlation with initial treatment failure and recurrence within 1 month after cure of abscesses and related infection [10] . Shock was defined as a systolic blood pressure of ≤ 90 mm Hg during hospitalization [11] .…”
Section: Examined Factors and Clinical Risk Factorsmentioning
Introduction: This study examined the risk factors for initial treatment failure in renal or retroperitoneal abscess as a multicenter study. Materials and Methods: This retrospective analysis investigated consecutive patients with renal or retroperitoneal abscess who were hospitalized in Japan. The outcomes of these patients were classified into “cured” and “failure or recurrence.” The potential clinical risk factors examined were abscess size, diabetes mellitus, major organ failure, laboratory data, fever, drainage, and causative organisms, for instance. Results: Of the 74 patients, 40 (54.1%) were diagnosed with renal abscess and 34 (45.9%) with retroperitoneal abscess, 51 (68.9%) were cured by initial treatments, and 23 (31.1%) underwent failure or relapse; 33 (44.6%) were men and 41 (55.4%) were women. In detail, 36 patients were cured by conservative therapy only. Our multivariate analysis data showed that renal failure was the only significant factor for initial treatment failure (p = 0.0281). Conclusions: Our multivariate analysis showed that renal failure was a significant risk factor for initial treatment failure or recurrence.
“…In this case, the abscess did not extend beyond the abdomen and the patient had persistent right-sided flank pain for 3 days prior to admission and upper back pain for 3 months. Most patients with retroperitoneal abscesses will present with nonspecific symptoms and signs [4].…”
Retroperitoneal abscesses are uncommon conditions with occult and insidious presentations. ere is often a lack of abdominal signs and ultrasound findings, causing a delay in diagnosis and definitive treatment, leading to poor patient outcomes. We report a case of right-sided retroperitoneal abscess of a 28-year-old female patient with diabetes mellitus. Prior to admission, the patient reported a vague 2 weeks history of right-sided back and abdominal pain and dysuria. She presented to our medical ward with suspected pyelonephritis with right-sided renal abscess. A retroperitoneal abscess involving the right renal fossa was revealed on an urgent CT scan. e patient underwent percutaneous ultrasound-guided pigtail catheter drainage. Patient clinically and biochemically improved with medical management gradually over 2 weeks. is case report highlights the importance of investigating for recurrent urinary tract infections of diabetics which are often overlooked in general practice.
“…[1,6] Primary infection (more common type) is due to hematogenous spread from an occult source usually located in the muscles and spine. [6,7] In index case source could not be found.…”
Section: Discussionmentioning
confidence: 99%
“…Limp may be present in older children and adults. [6] There is usually an absence of peritoneal signs leading to delay in diagnosis. In our case, retroperitoneal pus got accumulated in the extra-peritoneal space of the abdominal wall and tracked down along the psoas muscle to the extra-peritoneal space of the pelvic cavity, thus simulating an abdominal mass extending from the right sub-hepatic region to the pelvis.…”
Retroperitoneal abscess may simulate other abdominal masses. A 2-year-old girl presented with abdominal pain and lump in right iliac fossa for the last one week. Investigations revealed a mass extending from pelvis up to right sub-hepatic region. Diagnostic laparoscopy revealed an unremarkable peritoneal cavity, except that ascending colon up to hepatic flexure was elevated suggestive of retroperitoneal mass. A small flank incision was then made and abscess was drained.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.